Oxaliplatin-induced enteric neuronal loss and intestinal dysfunction is prevented by co-treatment with BGP-15.
Rachel M McQuadeVanesa StojanovskaRhian StavelyCara TimpaniAaron C PetersenRaquel AbaloJoel C BornsteinEmma RybalkaKulmira NurgaliPublished in: British journal of pharmacology (2018)
Our results showed that BGP-15 ameliorated oxidative stress, increased enteric neuronal survival and alleviated oxaliplatin-induced intestinal dysfunction, suggesting that BGP-15 may relieve the gastrointestinal side effects of chemotherapy.